Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes-Reference-Cited by-同舟云学术

Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes

Published:2017-06-30 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Arellano Gabriel,Acuña Eric,Reyes Lilian I.,Ottum Payton A.,De Sarno Patrizia,Villarroel Luis,Ciampi Ethel,Uribe-San Martín Reinaldo,Cárcamo Claudia,Naves Rodrigo

Funder

Fondo Nacional de Desarrollo Científico y Tecnológico

Comisión Nacional de Investigación Científica y Tecnológica

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference55 articles.

1. The clinical course of multiple sclerosis;Confavreux;Handb Clin Neurol,2014

2. Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?;Antel;Acta Neuropathol,2012

3. Immunological differences between classical phenothypes of multiple sclerosis;Iwanowski;J Neurol Sci,2015

4. The immunopathology of multiple sclerosis: an overview;Lassmann;Brain Pathol,2007

5. Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment response;Comabella;Curr Opin Neurol,2016

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quercetin regulates dendritic cell activation by targeting STAT4 in the treatment of experimental autoimmune encephalomyelitis;Toxicology and Applied Pharmacology;2024-07

2. Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b+ myeloid cells;Journal of Neuroinflammation;2024-05-31

3. Lymphocytic infiltration in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-05

4. T cell-mediated skin-brain axis: Bridging the gap between psoriasis and psychiatric comorbidities;Journal of Autoimmunity;2024-04

5. Complete Freund’s adjuvant as a confounding factor in multiple sclerosis research;Frontiers in Immunology;2024-02-15